Get the Stockscreener App
0.3411
0.84%
-0.0029
After Hours:
.36
0.0189
+5.54%
Co Diagnostics Inc stock is traded at $0.3411, with a volume of 598.92K.
It is down -0.84% in the last 24 hours and up +34.45% over the past month.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
See More
Previous Close:
$0.344
Open:
$0.3401
24h Volume:
598.92K
Relative Volume:
0.28
Market Cap:
$13.14M
Revenue:
$7.11M
Net Income/Loss:
$-41.28M
P/E Ratio:
-0.2472
EPS:
-1.38
Net Cash Flow:
$-26.84M
1W Performance:
+10.10%
1M Performance:
+34.45%
6M Performance:
-31.78%
1Y Performance:
-73.56%
1-Day Range:
$0.3234
$0.3688
1-Week Range:
$0.2989
$0.3688
52-Week Range:
$0.2275
$1.40
Co Diagnostics Inc Stock (CODX) Company Profile
Name
Co Diagnostics Inc
Sector
Industry
Phone
(801) 278-9769
Address
4049 SOUTH HIGHLAND DRIVE, SALT LAKE CITY
Compare CODX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CODX
Co Diagnostics Inc
|
0.3411 | 11.81M | 7.11M | -41.28M | -26.84M | -1.38 |
|
ABT
Abbott Laboratories
|
133.73 | 225.15B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.71 | 155.92B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
383.34 | 146.41B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
94.03 | 118.42B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
77.57 | 45.96B | 5.69B | 1.41B | 577.90M | 6.95 |
Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-12-22 | Downgrade | Sidoti | Buy → Neutral |
| Dec-29-21 | Initiated | Sidoti | Buy |
| Mar-29-21 | Downgrade | Maxim Group | Buy → Hold |
| May-20-20 | Upgrade | Maxim Group | Hold → Buy |
| May-18-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-09-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-03-20 | Downgrade | Maxim Group | Buy → Hold |
View All
Co Diagnostics Inc Stock (CODX) Latest News
Volatility clustering patterns for Co Diagnostics Inc.Weekly Trend Report & AI Enhanced Execution Alerts - Newser
Regression analysis insights on Co Diagnostics Inc. performanceJuly 2025 Catalysts & Safe Capital Investment Plans - Newser
Long term hold vs stop loss in Co Diagnostics Inc.Index Update & Precise Buy Zone Tips - Newser
Co Diagnostics Inc. stock prediction for this weekWeekly Trend Report & Capital Efficiency Focused Strategies - Newser
Short interest data insights for Co Diagnostics Inc.2025 Market Sentiment & AI Driven Stock Movement Reports - Newser
Is this a good reentry point in Co Diagnostics Inc.Market Trend Review & Risk Managed Investment Strategies - Newser
How to use Fibonacci retracement on Co Diagnostics Inc.Earnings Summary Report & Accurate Entry/Exit Alerts - Newser
Key metrics from Co Diagnostics Inc.’s quarterly dataMarket Growth Report & Stepwise Entry/Exit Trade Alerts - Newser
Real time pattern detection on Co Diagnostics Inc. stockJuly 2025 Macro Moves & High Conviction Buy Zone Alerts - Newser
Published on: 2025-09-12 05:17:58 - Newser
Ranking Co Diagnostics Inc. among high performing stocks via tools2025 Fundamental Recap & Low Risk Growth Stock Ideas - Newser
Co-Diagnostics, Inc. Performs Analysis of Chikungunya Co-Primers® to Confirm Reactivity Against Known Virus Strains - BioSpace
Published on: 2025-09-12 04:09:04 - Newser
Is it time to cut losses on Co Diagnostics Inc.July 2025 Volume & Comprehensive Market Scan Reports - Newser
Candlestick signals on Co Diagnostics Inc. stock todayJuly 2025 Patterns & Risk Controlled Daily Plans - Newser
5.6B People at Risk: Co-Diagnostics Validates Critical Chikungunya Test Against 1,200+ Virus Strains - Stock Titan
Will Co Diagnostics Inc. see short term momentum2025 Price Action Summary & Reliable Entry Point Trade Alerts - Newser
How Co Diagnostics Inc. stock performs during market volatilityTrade Analysis Summary & Free Fast Gain Swing Trade Alerts - Newser
Chart based analysis of Co Diagnostics Inc. trendsQuarterly Market Summary & Advanced Swing Trade Entry Alerts - Newser
What indicators show strength in Co Diagnostics Inc.July 2025 Fed Impact & Community Shared Stock Ideas - Newser
How to forecast Co Diagnostics Inc. trends using time seriesMarket Trend Review & Smart Allocation Stock Reports - Newser
Quantitative breakdown of Co Diagnostics Inc. recent moveQuarterly Earnings Report & Free Fast Gain Swing Trade Alerts - Newser
Analyzing Co Diagnostics Inc. with multi timeframe chartsPortfolio Growth Summary & Long-Term Investment Growth Plans - Newser
Visualizing Co Diagnostics Inc. stock with heatmaps2025 Top Gainers & Free Weekly Watchlist of Top Performers - Newser
Innovative PCR Testing Platform Earns Co-Diagnostics Major Recognition at Utah Business 2025 Awards Summit - Stock Titan
Co Diagnostics Inc Stock (CODX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.14%
1.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):